Information Provided By:
Fly News Breaks for December 4, 2015
BLUE, ZIOP, VTAE, TKAI, TSRO, SPG, TU, SANM, SGMO, RSE, RCI, REGN, RGLS, QCOM, PXLW, PEI, PN, OMED, NMBL, MYOK, MMS, MAT, MRKT, MAC, LNKD, ISIS, ICPT, IPAR, INFN, IPHI, HAS, HALO, GIG, GGP, GWGH, FPRX, FINL, FATE, FGEN, DOV, DMTX, CLS, CFX, CPLP, BCE, AGTC, AMGN, AFCO, AFMD
Dec 4, 2015 | 10:03 EDT
Today's noteworthy initiations include: Affimed Therapeutics (AFMD) initiated with an Outperform at Wells Fargo... American Farmland (AFCO) initiated with an Outperform at Raymond James... Amgen (AMGN) initiated with a Market Perform at Wells Fargo... Applied Genetic (AGTC) initiated with an Outperform at Wells Fargo... BCE (BCE) initiated with a Buy at Goldman... Capital Product (CPLP) initiated with a Buy at Janney Capital... Celestica (CLS) initiated with a Neutral at B. Riley... Colfax (CFX) initiated with a Perform at Oppenheimer... Dimension Therapeutics (DMTX) initiated with an Outperform at Wells Fargo... Dover (DOV) initiated with a Perform at Oppenheimer... Fate Therapeutics (FATE) initiated with an Outperform at Wells Fargo... FibroGen (FGEN) initiated with a Buy at Citi... Finish Line (FINL) initiated with a Hold at BB&T... Five Prime (FPRX) resumed with an Outperform at Wells Fargo... Foot Locker (FL) initiated with a Buy at BB&T... GWG Holdings (GWGH) initiated with a Buy at Roth Capital... General Growth (GGP) initiated with an Outperform at Boenning & Scattergood... GigOptix (GIG) initiated with a Buy at Sterne Agee CRT... Halozyme (HALO) initiated with an Outperform at Wells Fargo... Hasbro (HAS) initiated with a Hold at Jefferies... Infinera (INFN) initiated with an Outperform at Raymond James... Inphi (IPHI) initiated with a Buy at Sterne Agee CRT... Inter Parfums (IPAR) initiated with an Overweight at KeyBanc... Intercept (ICPT) initiated with a Market Perform at Wells Fargo... Isis Pharmaceuticals (ISIS) initiated with an Outperform at Wells Fargo... LinkedIn (LNKD) initiated with a Buy at Nomura... Macerich (MAC) initiated with an Outperform at Boenning & Scattergood... Markit (MRKT) initiated with a Hold at Cantor... Mattel (MAT) initiated with a Buy at Jefferies... Maximus (MMS) initiated with a Buy at Stifel... MyoKardia (MYOK) initiated with an Outperform at Wells Fargo... Nimble Storage (NMBL) initiated with an Overweight at JPMorgan... OncoMed (OMED) initiated with an Outperform at Wells Fargo... Patriot National (PN) initiated with a Buy at Compass Point... Pennsylvania REIT (PEI) initiated with a Neutral at Boenning & Scattergood... Pixelworks (PXLW) initiated with a Buy at Craig-Hallum... Qualcomm (QCOM) initiated with an Overweight at Pacific Crest... Regeneron (REGN) initiated with an Outperform at Wells Fargo... Regulus (RGLS) initiated with an Outperform at Wells Fargo... Rogers Communications (RCI) initiated with a Neutral at Goldman... Rouse Properties (RSE) initiated with a Neutral at Boenning & Scattergood... Sangamo (SGMO) initiated with an Outperform at Wells Fargo... Sanmina (SANM) initiated with a Buy at B. Riley... Simon Property (SPG) initiated with an Outperform at Boenning & Scattergood... TELUS (TU) initiated with a Neutral at Goldman... TESARO (TSRO) initiated with an Outperform at Wells Fargo... Tokai Pharmaceuticals (TKAI) initiated with an Outperform at Wells Fargo... Vitae Pharmaceuticals (VTAE) initiated with an Outperform at Wells Fargo... ZIOPHARM (ZIOP) initiated with an Underperform at Wells Fargo... bluebird bio (BLUE) initiated with an Outperform at Wells Fargo.
News For AFMD;AFCO;AMGN;AGTC;BCE;CPLP;CFX;CLS;DMTX;DOV;FGEN;FATE;FINL;FPRX;GWGH;GGP;GIG;HALO;HAS;IPHI;INFN;IPAR;ICPT;ISIS;LNKD;MAC;MRKT;MAT;MMS;MYOK;NMBL;OMED;PN;PEI;PXLW;QCOM;RGLS;REGN;RCI;RSE;SGMO;SANM;TU;SPG;TSRO;TKAI;VTAE;ZIOP;BLUE From the Last 2 Days
MAT
Apr 23, 2024 | 18:46 EDT
In an interview on CNBC's Mad Money, Ynon Kreiz said Mattel has a very clear strategy to grow its IP-driven toy business. The priority is "first and foremost" to drive organic growth. He "couldn't be more excited" with Barbie's growth trajectory.
MAT
Apr 23, 2024 | 17:33 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSAudioEye (AEYE) up... To see the rest of the story go to thefly.com. See Story Here
MAT
Apr 23, 2024 | 17:19 EDT
Sees FY24 free cash flow $500M. Says has more than $1.1B in cash. Says bent portfolio well positioned with no maturities until 2026. Says trends in consumer demand for product improved through the quarter and expects to outpace the industry and gain market share in 2024. Says retail inventory levels have been largely corrected. Says now at appropriate levels to support the business going forward. Comments taken from Q1 earnings conference call and investor presentation slides.
QCOM
Apr 23, 2024 | 16:25 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here
MAT
Apr 23, 2024 | 16:09 EDT
Reports Q1 revenue $810M, consensus $831.8M. Ynon Kreiz, Chairman and CEO of Mattel, said: "We are off to a good start to the year with significant gross margin expansion, positive Adjusted EBITDA, and very strong improvement in free cash flow. Trends in consumer demand for our product improved through the quarter and we expect to outpace the industry and gain market share in 2024. We are executing our strategy to grow our IP-driven toy business and expand our entertainment offering." Anthony DiSilvestro, CFO of Mattel, added: "We achieved strong bottom-line results, primarily driven by margin expansion, repurchased $100 million of shares in the quarter, and are on track to meet our full year guidance. We expect to continue to benefit from the Optimizing for Profitable Growth program, which is targeting $60 million in cost savings in 2024 and a total of $200 million in cost savings by 2026."
QCOM
Apr 23, 2024 | 11:57 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here
BCE
Apr 23, 2024 | 11:39 EDT
As previously reported, CIBC analyst Stephanie Price upgraded BCE to Outperformer from Neutral with an unchanged price target of C$52. The stock is trading at a five-year trough multiple amid heightened competitive intensity, volatile interest rates and concerns around free cash flow growth, notes the analyst. While the firm recognizes these concerns, it believes that they have been "priced into the name at these levels," the analyst tells investors.
CLS
Apr 22, 2024 | 11:09 EDT
BMO Capital raised the firm's price target on Celestica to C$48 from C$37 and keeps an Outperform rating on the shares.